Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00372385
What this trial is testing

Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 334
Testing effectiveness (Phase 2)Study completedNCT00352235
What this trial is testing

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 36
Testing effectiveness (Phase 2)UnknownNCT01949168
What this trial is testing

A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV

Who this might be right for
Chronic Hepatitis C
St Vincent's Hospital Melbourne 30
Not applicableUnknownNCT01758939
What this trial is testing

Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

Who this might be right for
Hepatitis C, Chronic
Cairo University 100,000
Post-approval studies (Phase 4)Study completedNCT01258101
What this trial is testing

PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 395
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Not applicableStudy completedNCT00726557
What this trial is testing

Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)

Who this might be right for
Hepatitis C, ChronicSubstance Abuse, Intravenous
Merck Sharp & Dohme LLC 246
Testing effectiveness (Phase 2)Study completedNCT01710501
What this trial is testing

Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)

Who this might be right for
Chronic Hepatitis C (CHC)
Merck Sharp & Dohme LLC 87
Testing effectiveness (Phase 2)Study completedNCT04387539
What this trial is testing

ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants

Who this might be right for
Chronic Hepatitis C Virus Infection
Beni-Suef University 94
Not applicableUnknownNCT06463912
What this trial is testing

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

Who this might be right for
Hepatitis C Virus Infection
Asociación Colombiana de Hepatología 205
Post-approval studies (Phase 4)Study completedNCT01097395
What this trial is testing

Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus
University of Colorado, Denver 35
Testing effectiveness (Phase 2)Study completedNCT02226952
What this trial is testing

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 51
Large-scale testing (Phase 3)Study completedNCT01433887
What this trial is testing

Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 535
Large-scale testing (Phase 3)Study completedNCT02442284
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis CCirrhosisHepatitis C Virus
AbbVie 99
Early research (Phase 1)Ended earlyNCT00277758
What this trial is testing

Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I

Who this might be right for
Hepatitis C
Weill Medical College of Cornell University 18
Large-scale testing (Phase 3)Study completedNCT02576314
What this trial is testing

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 48
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Large-scale testing (Phase 3)Study completedNCT01718158
What this trial is testing

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 444
Not applicableStudy completedNCT00216775
What this trial is testing

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kyoto University 50
Not applicableStudy completedNCT03071133
What this trial is testing

Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 344
Next Page